Topics
Sector
Geography
Subject

Videos Library

All Videos

1855
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

The Evidence Life Science Videos Library is the full collection of video recordings (and supporting documentation) from all Evidence Life Science events.

Latest Videos

Presentation

Translating insights into content

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Effectively 
  • Efficiently
  • Responsibly 
Speaker

Tessa Pugh

CEO
PharmaReview

Presentation

Deep RWE: The most realistic clinical data possible

Related topics: Real-World Evidence & Late-Phase Research
Availability: FREE
  • Retrieving the actual complete information of what is happening at each point of care
  • Having access to the complete medical records information: Every single patient, every single variable, the most realistic data source possible
  • In order to get this, you need a system which is able to retrieve information:
    • From any healthcare provider (as long as they have electronic health records -EHR-, paper doesn't work)
    • Natural Language Processing: 80% of the variables and outcomes are going to be in the clinical narratives´ free text
Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

Presentation

Maximising the omnichannel ecosystem for medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Ensuring accurate KOL ID for engagement
  • Utilising engagement channels for optimal outcomes
  • Connecting data to verify understanding & strategy
Speaker

Nina Levin

Vice President - Client Success
Within3

Presentation

Paving the way: The reality of implementing omnichannel in medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speakers

James Turnbull

Global Head of Omnichannel Communications
OPEN Health

Jenny Ghith

Senior Director, Omnichannel Strategy and Innovation Lead, Global Scientific Communications 
Pfizer Oncology

Presentation

KOL insights in a digital world

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices.  Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.

Speaker

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Presentation

Community engagement from a medical publisher`s point of view

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

Let's take the idea of KOL engagement a bit further! Discover how to bridge the knowledge gap in multiple communities by sharing scientific information with relevant stakeholders simultaneously thus leveraging existing networks, relationships, and channels to foster connections. Join us in exploring the ideas and hear a few practical real-life cases of community engagement.

Speakers

Iola Forster

Strategic Competence Lead, Industry & Society Services
Karger Publishers

Geoff Covey

General Manager, Karger UK
Karger Publishers

Presentation

Digital capabilities: Closing the medical affairs "Insight Gap"

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Tim Murphy

Senior Director of Client Partnerships
Within3

Presentation

Leveraging scientific activity insights to inform medical strategies

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

As the industry continues to rethink the profile of medical affairs, it must seek out new competencies, technology solutions, and data sources that better support patient-centric outcomes. Medical affairs leaders are at the forefront of this evolution and newly positioned to rewrite the traditional corporate formula for success. Understanding and analysing the scientific share of voice of competitive compounds has become increasingly critical when evolving commercialisation strategies. These highly specific insights create a foundation for continuous improvements and opportunities to act with greater focus. These efforts allow teams to accurately benchmark external relations and inform strategic engagement.
As innovation increases the complexity of care and the scientific demand of the treating community grows, the ability to identify and engage community leaders using insights from medical claims data is now critical for long-term success.

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Presentation

Raising the bar on RWE: AI, Big Data, NLP and a methodology that sets the gold standard

Related topics: Real-World Evidence & Late-Phase Research, Digital & Technology
Availability: FREE

Traditional methods of evidence generation from electronic health records are no longer fit for purpose.  Discover how AI techniques such as clinical natural language processing (cNLP) can generate deep RWE to deliver clinical and economic value for industry. Hear about:

·  The limitations of traditional methods of evidence generation from electronic health records

·  The benefits of AI-based techniques such as cNLP

·  A gold standard for high-quality RWE for deeper insights at scale and speed

·  Ideas for applying deep RWE across the Pharma R&D and commercial lifecycle

Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

Presentation

Digital capabilities: Closing the medical affairs "Insight Gap"

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

How to thrive in this new “hybrid” world

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Rosie Humphreys

Digital Communications Director 
Open Health 

Presentation

For greater value start with deep RWE

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

Traditional methods alone for evidence generation in electronic health records are no longer fit for purpose. We discuss how AI applied to electronic health records for Deep RWE, at scale and speed, can generate greater scientific and economic value for Medical Affairs:

  • AI in healthcare today - reality v myth
  • Disrupting the RWE status quo
  • Deep RWE for clinical and economic value
Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

Presentation

Positively challenging: A new mindset for HCP engagement in Medical Affairs

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
  • How can medical affairs navigate the challenges of rapidly changing internal and external landscapes?
  • What value can medical affairs deliver with a new mindset?
  • How can we empower teams to drive impactful engagement with the healthcare community?
Speakers

Jessica Ingram

Senior Vice President, Learning & Development
OPEN Health Medical Communications

Sophie Officer-Thorley

Senior Account Manager - Learning and Development
OPEN Health Medical Communications

Presentation

Market assessment to fuel actionable insights for medical affairs

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE

The remit for Medical Affairs is extensive with a key objective of gathering actionable insights into clinician behaviour to identify practice and prescription patterns—and the rationales behind physician choices.  Join us to learn more about closing knowledge gaps to maximize the impact of your medical activities.

Speaker

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Presentation

Getting more out of external stakeholder engagement: Developing and tracking perception journeys

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
  • Assist with medical objective based planning
  • Measure impact of medical affairs engagement activities
  • Demonstrate medical affairs value internally
Speaker

Steven Gomez

Solutions Design Director
Monocl

Presentation

Adding instant digital capabilities to your medical teams without increasing workloads

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

Informing oncology strategies through insights and engagement

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE

Innovation in an already crowded oncology space has created a challenge for medical affairs.  The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the  scientific need of experts, while continuously demonstrating value.  To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to  leverage this information to inform targeted decisions and investments. 

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Presentation

AI-driven literature discovery provides critical context for interpreting registry information

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speakers

Jeffrey Saffer

CEO and Co-founder 
Quertle

Chahrazed Poignant

Business Development Manager
Karger

Gregor Bangert

Regional Manager
Karger

Presentation

Using RWD and machine Learning to drive patient identification in rare diseases

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Orphan Drugs, Digital & Technology
Availability: FREE
  • UK Data Sources and Access:
    • Hospital Episode Statistics
    • Primary care datasets – GPES, CPRD, OPCRD
  • Overview of key processes
  • Expanding the global reach
  • What the future could hold?
Speaker

Tony Cox

Development Director Real-World Evidence
OPEN Health

Presentation

The power of deep real-world evidence

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE

Recent advances in AI such as clinical natural language processing (NLP) and Machine Learning are enabling the mining of data from the EMR across multiple sites and in multi-languages enabling new insights and accelerating innovation.

  • From RWD to deep RWE
  • Ensuring patient data privacy and security
  • Developing the research eco-system
  • Deep Real World Evidence in practice - the big COVID data study
Speaker

Ignacio Medrano

Founder & Chief Medical Officer 
Savana 

Presentation

The power of patients platform for real-world evidence generation

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE

Learn about the power of patient insights and discover real-world patients' insights generation. Understand the value of patients' insights at each step of a product's lifecycle from Target product profiling to Preference study, through Clinical trial optimization and patient's experience (disease and treatment management, unmet needs..).

Speaker

Carine Odouard

Global Business Development Director - Head of Real World Evidence
Carenity - EvidentIQ Group

Presentation

How value-based approach is transforming the MedTech industry

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Integrating market access, medical affairs and deep clinical understanding
  • Building a strategy with KOL engagement and collaboration with scientific societies - a case study explaining the process and decision-making algorithms
  • Clinical guidelines, the reimbursement system and medical standards and protocols as a key focus of the strategy
Speaker

Julya Zuenkova

Business Development Director
Xstrahl Group

Presentation

From value-based healthcare to network value

Related topics: MedTech, Market Access & HEOR
Availability: FREE

COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.

Speaker

Ernesto M. Nogueira

CEO and Founder
ValueConnected

Presentation

Creating Product Value To Capture Market Opportunities in Post-COVID era – A multi-disciplinary roadmap for success

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Key decisions of today that brings you into the world of opportunities tomorrow
  • Setting out Product Claims with recognizable aspirational value.
  • Understanding pricing & reimbursement landscape and payers needs
  • Designing adequate evidence to demonstrate this value for regulatory and reimbursement purposes.
  • Informed choices for stronger claims and data generation with the full circle of multi-disciplinary insights  
  • Defining key success factors to capture new market access opportunities
Speakers

Claus Schaffrath

Managing Director, MD squared

Katarzyna Kolasa

Sr. Consultant Health Economics, MD squared
Professor & Head of Health Economics & Healthcare Management Division, Kozminski University

Presentation

Successful evidence development for global launches

Related topics: MedTech, Market Access & HEOR
Availability: FREE

In today's demanding world of national requirements, how can companies develop the right evidence portfolio to succeed? How can they integrate evidence for payers with their regulatory studies?  This in depth review will discuss core principles in evidence development for diagnostics and therapeutic medical devices, and how these concepts can align with the requirements of the major global markets -- the UK, France, Germany, Japan and the USA. Learn about the evolving landscape of evidence demands in:

  • The UK, with NICE's development of new pathways for innovative devices
  • France's Forfeit Innovation and evidence demands
  • Germany's NUB evidence review requirements for high risk devices
  • Japan's emerging new pathways for breakthrough innovations
  • The US Medicare programs special coverage of FDA designated Breakthrough Devices
Speaker

Stephen Hull

Principal and Founder
Hull Associates

Presentation

Omnichannel in Medical Affairs - an evidence-based approach to personalising healthcare communications

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • So what does omnichannel actually mean for Medical Affairs?
  • Examples of evidence and data-based healthcare communications
  • Right message, right place, right audience
Speaker

James Turnbull

Senior Vice President, Omnichannel & Digital
OPEN Health

Presentation

Beyond Knowledge Transfer: Generating Actionable Insights for Medical Affairs

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speakers

Christina Hoffman

Global Head, Medscape Medical Affairs
Medscape Medical Affairs

Alessandro Pontes-Arruda

Vice-President, U.S. Medical Head Cardiovascular and Established Products
Sanofi

Gokhan Tanju

Executive Director, Business Intelligence
Medscape Medical Affairs

Presentation

Rapid case study: Maximising virtual KOL engagement in practice

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

Stakeholder mapping & engagement in established and emerging markets

Related topics: MedTech, Diagnostics, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speaker

Eric Noehrenberg

President
NIPC

Presentation

MedTech KOL Engagement During COVID: Real-world case studies

Related topics: MedTech, Diagnostics, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

Informing oncology strategies through insights and engagement

Related topics: Medical Affairs & Stakeholder Engagement, Oncology
Availability: FREE

Innovation in an already crowded oncology space has created a challenge for medical affairs.  The proliferation of compounds in development has reinforced the need to accurately identify strategic opportunities, address the  scientific need of experts, while continuously demonstrating value.  To achieve these goals, medical leaders must develop clear, comprehensive insights. With an immense amount of data at their disposal, medical affairs must develop novel approaches to  leverage this information to inform targeted decisions and investments. 

Speaker

Robert Groebel

Vice President - Global Medical Strategy
Monocl

Presentation

Oncology-Specific KOL Engagement During COVID: Real-world case studies

Related topics: Medical Affairs & Stakeholder Engagement, Oncology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

How to maintain valuable peer-to-peer dialogue in a virtual setting? Insights and learnings from 2020

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Insights and feedback from HCPs on 2020 virtual activities
  • Recommendations for impactful virtual engagements in 2021
  • How to effectively have peer-to-peer conversations virtually
Speaker

Gemma Allen

Head of Digital Communications
Open Health

Presentation

Digital transformation for medical affairs in practice

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

KOL Engagement from a Medical Publisher’s viewpoint

Related topics: Medical Affairs & Stakeholder Engagement
Availability: FREE
  • How KOL-expertise can be accessed to curate and publish high quality content for a variety of target audiences
  • Possibilities of engaging different types of KOLs to fill knowledge gaps via medical communications.
  • Values and benefits of co-operating with medical publishing professionals when involving and/or addressing KOLs.
Speakers

Joachim Flickinger

Head of Clinical & Patient Markets
Karger Publishers, Switzerland

Iola Gulijew

Strategic Competence Lead, Industry & Society Services
Karger Publishers, Switzerland

Presentation

Within3 product showcase

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

Within3 offers a virtual engagement platform that gives stakeholders the freedom to communicate anytime, anywhere, on any device

Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

Rapid case study: Maximising virtual KOL engagement in practice

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Luke Rogers

Senior Director, Business Partnerships
Within3

Presentation

Building best-in-class MSL functions for the 21st century healthcare industry

Related topics: Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
Speaker

Helen Kane

Founder & Managing Director
ONE MSL, UK

Presentation

Considerations for evidence generation early in the product development process

Related topics: Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Clinical
Availability: FREE
Speaker

Sergio Diaz

Patient-Centred Outcomes Consultant
OPEN VIE

Presentation

Considerations for evidence generation early in the product development process

Related topics: Market Access & HEOR, Medical Affairs & Stakeholder Engagement, Clinical
Availability: FREE
Speaker

Amanda Pulfer

Strategic Director
OPEN VIE

Presentation

Identifying when and where real world evidence (RWE) can provide credible evidence of treatment effect

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Leading insights on the role of RWE in regulatory decision-making
  • Lessons from inside the FDA's RCT-DUPLICATE demonstration
  • Implications for Medical Affairs planning and key decision makers
Speaker

Jeremy Rassen

President and Chief Science Officer
Aetion, USA

Presentation

How Medical Affairs can break the mold in capability deployment: Copy review in action @ PharmaReview

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

Tessa Pugh

CEO
PharmaReview, UK

Presentation

Designing and implementing training programs for Medical Affairs professionals

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speakers

William Soliman

President & CEO
Accreditation Council for Medical Affairs 

Eric Bouilloux

Associate VP, Scientific Affairs - Operations
Accord Healthcare, UK

Presentation

Leveraging online discussion platforms for optimal insight generation & stakeholder engagement

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement & insight retention
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges and drive value-added insight development.
  • Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker

Andy Bowman

Managing Director
Within3

Presentation

Which skills are required from Medical Affairs professionals today?: Retooling your team to maximise performance

Related topics: Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

Jessica Ingram

Managing Director
OPEN Health Medical Communications

Presentation

Local Market Access in Germany

Related topics:
Availability: FREE
  • Addressees & Purposes
  • Challenges in compiling the right data
  • Current solutions and suitable data sources
  • Outlook to the future: a new claims data treasure through the digital care act?
Speaker

Michael Weisser
CEO
AIM Gmbh (Assessment-in-Medicine)

Presentation

Principles of MedTech market access: how to get technologies to patients faster

Related topics:
Availability: FREE

The principles of market access differ greatly from traditional 4 P  product price place promotion Marketing. The winning combination of clear demonstration of Patient, Provider Payer and Product benefits (Optimizing price but maximising the availability to patients who need the technology most) to HTA’s leads to faster adoption meaning patients receive great technologies sooner.

Speaker

Michael Branagan-Harris
CEO
Device Access UK

Presentation

Translating market needs into actual value stories

Related topics:
Availability: FREE
  • Identifying decision-makers’ needs
  • Assessing the relevant data to support claims
  • Building a concrete value story
  • Next steps: Teams, not tools, demonstrate value
Speaker

Richard Charter
Director Value-Based Healthcare
ValueConnected

Presentation

Europe's MDR and proposed pan-European HTA process for reimbursement

Related topics:
Availability: FREE

While evidence requirements have changed under the new European framework for CE arking, the movement towards pan-European Health Technology Assessment also has gained traction, prompting greater conformity of HTA evidence requirements and "transplantation" of evidence reviews across geographies within the European Union.  Companies can expect CE Mark requirements to be more aligned with the demands of HTA bodies for reimbursement, but the challenges for medical device firms are greater, as local HTA bodies may be commissioned to implement assessments that have a pan-European impact. 

Speaker

Stephen Hull
Principal and Founder
Hull Associates, USA

Presentation

Aligning commercially-focused teams to best practices in Value-Based Healthcare

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE

Value Based Healthcare requires a new way of thinking.  It requires fluently navigating clinical outcomes and economic costing.  This presentation will cover WHY VBHC is necessary, HOW Value based procurement enables VBHC, WHO needs to be involved in the collaborative dialogue, and WHAT the role of VBAPs are in overcoming clinical and economic uncertainty to drive medtech adoption.

Speaker

Ernesto M. Nogueira
CEO and Founder
ValueConnected

Register to view both free videos and browse premium content (and event documentation).

1855
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!